Physician profile
Zachary S Collins
NPI 1639229263
$302,378.86
in general payments reported to CMS, 2019-2025
24 companies · $87K in 2025
The $87K reported for 2025 was more than what 99% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39K · 2020: $39K · 2021: $42K · 2022: $25K · 2023: $20K · 2024: $50K · 2025: $87K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $92K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $39K · Travel and Lodging: $13K · Honoraria: $6,500 · Food and Beverage: $5,650.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $92,035.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $39,339.00 |
| Travel and Lodging | $13,460.74 |
| Honoraria | $6,500.00 |
| Food and Beverage | $5,649.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sirtex Medical INC | $247,021.78 | 2019-2025 | Sir-Spheres Microspheres, Lava Les (Liquid Embolic System) |
| Balt USA, LLC | $24,788.75 | 2021-2025 | Prestige Coil System, Optima Coil System |
| Trisalus Life Sciences, INC. | $8,795.78 | 2021-2025 | Trinav Infusion System |
| Terumo Medical Corporation | $6,510.81 | 2023 | Azur Cx Detachable, Glidewire, Navicross |
| Penumbra, INC. | $5,675.76 | 2019-2025 | Indigo System, Penumbra System, Ruby Coil |
| Delcath Systems | $2,173.31 | 2024-2025 | Hepzato Kit, Hepzato Kit |
| Bard Peripheral Vascular, INC. | $1,587.64 | 2020-2025 | Peritx, Venovo |
| Telix Pharmaceuticals | $1,281.22 | 2023-2024 | Illuccix |
| Siemens Medical Solutions USA, INC. | $1,125.94 | 2022-2025 | |
| Philips North America LLC | $783.90 | 2023 | |
| Medtronic, INC. | $594.79 | 2021-2024 | Reliant |
| Becton, Dickinson and Company | $414.00 | 2024-2025 | Powerpicc, Sherlock |
| Stryker Corporation | $371.89 | 2025 | Flowtriever |
| Cook Incorporated | $300.00 | 2023 | |
| Inari Medical, INC. | $252.80 | 2019-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Histosonics, INC. | $189.78 | 2024 | |
| Boston Scientific Corporation | $150.00 | 2024 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Ekos Corporation | $116.44 | 2019 | |
| Angiodynamics, INC. | $104.99 | 2019-2022 | |
| Abbott Laboratories | $50.77 | 2022-2025 | Diamondback Peripheral, Emboshield Nav6 |
| W. L. Gore & Associates, INC. | $38.76 | 2019 | |
| Cordis US Corp. | $22.19 | 2022 | |
| Cardiovascular Systems INC. | $15.20 | 2022 | |
| Argon Medical Devices, INC. | $12.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zachary Collins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.